Cord Blood America Now Part of New ETF Innovators Stem Cell Index

Monday February 9, 2009, 9:35 am EST

SANTA MONICA, CA--(MARKET WIRE)--Feb 9, 2009 -- Cord Blood America, Inc. (OTC BB:CBAI.OB - News), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells to families nationwide and internationally, said today that the Company is now listed on the ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks. For more information, see the social media news room at http://www.intelligendo.com.

ETF Innovators, known for creating new global equity indexes with a focus in the healthcare industry, will track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and regenerative medicine space.

"We are pleased by this recognition. Two thousand and nine has been, so far, both very interesting and positive for stem cell companies, and we're pleased to see this impressive index following our sector," said Matthew Schissler, Founder and CEO of Cord Blood America.